Answers are grounded in this paper and cite their sources.
A double antibody radioimmunoassay for rat luteinizing hormone (LH) has been developed. Purified rat LH (prepared by ammonium sulfate fractionation, ion exchange chromatography and gel filtration) with a potency equivalent to that of NIH-LH-S1 was iodinated with 131I using chloramine-T. Antiserum capable of neutralizing rat LH, obtained by repeated immunization of rabbits with partially purified hormone, was absorbed with serum from hypophysectomized rats prior to use in the radioimmunoassay. Satisfactory dose-response curves were obtained with 0.0004 to 0.005 μg purified rat LH (90–20% bound). A variety of pituitary extracts with widely varying ratios of LH and follicle stimulating hormone (FSH) were bioassayed and radioimmunoassayed with the same standards in separate laboratories. In terms of NIH-FSH-S1 and NIH-LH-S1, pituitary extracts containing 1600 times as much FSH as LH, and, conversely, at least 10 times as much LH as FSH, were found to have potency estimates by radioimmunoassay which were in close agreement with bioassay values (indices of discrimination 0.79–1.3). Similarly, radioimmunoassay and bioassay estimates of the LH concentration of pituitary extracts containing LH: thyroid stimulating hormone (TSH) ratios which varied by more than 3000-fold were in good agreement (indices of discrimination 0.8–1.3). These observations suggest that FSH and TSH do not interfere with the measurement of LH by radioimmunoassay. Estimates of the concentration of LH in sera and serum extracts obtained by radioimmunoassay were lower than, but proportional to, estimates obtained by bioassay. (Endocrinology83: 1004, 1968)
No takes yet. Share an insight, caveat, or question.
Monroe et al. (1968) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: